Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Acadia Healthcare Company Inc (ACHC) vs Tesla, Inc. (TSLA) Price & Performance

Acadia Healthcare Company Inc
Tesla, Inc.

Price performance

Price movement over the last 24 hours

Key statistics

Acadia Healthcare Company Inc vs Tesla, Inc. — how do they compare? Acadia Healthcare Company Inc trades at $30.67 (market cap $2.94B), while Tesla, Inc. trades at $393.64 (market cap $1.51T). The key difference: Tesla, Inc. is far larger — about 513.6× Acadia Healthcare Company Inc's market cap, and Acadia Healthcare Company Inc is trading nearer its 52-week high, Tesla, Inc. nearer its low. Which is the better fit depends on your goals.

ACHCTSLA
Market Cap
$2.94B$1.51T
Sector
HealthConsumer Cyclical
52-Week High
$31.92$489.88
52-Week Low
$11.68$295.88
Enterprise Value
$5.45B$1.48T

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Acadia Healthcare Company Inc

ACHC trades at $31.09, down 2.57% today but maintains a bullish technical outlook with strong moving average support. The company shows operational strength with three consecutive earnings beats, though profitability remains challenged with a -32.84% net margin. Analyst consensus is strongly bullish with 68% buy ratings, while recent news highlights the company's strategic shift toward profitability and rising behavioral health demand.

The stock presents a mixed opportunity with strong technical momentum and analyst support offset by persistent profitability challenges. Key catalysts include continued earnings outperformance and successful execution of the turnaround strategy, while risks center on margin pressures and high short interest that could limit upside potential.

Tesla, Inc.

Tesla (TSLA) trades at $393.93, down 6.16% over 24 hours, reflecting recent market pressure. The stock shows mixed technical signals with a neutral overall outlook, while fundamentals reveal a high valuation (P/E 369.63) and declining profitability margins. Recent news highlights regulatory approval for driver-assistance software in Europe and a strategic pivot toward robotics and AI, though near-term delivery misses and competition weigh on sentiment.

Tesla's outlook balances long-term growth potential in autonomy and energy against near-term execution risks and rich valuations. Investment opportunity hinges on successful scaling of AI and robotaxi initiatives, but risks include intense EV competition, margin compression, and reliance on future technology adoption. Analysts remain divided, with a consensus price target of $429.91 suggesting moderate upside from current levels.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Acadia Healthcare Company Inc

Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.

Read more on ACHC

About Tesla, Inc.

Tesla Inc. designs, manufactures, and sells high-performance electric vehicles and electric vehicle powertrain components. The Company owns its sales and service network and sells electric power train components to other automobile manufacturers. Tesla serves customers worldwide.

Read more on TSLA